Oral valganciclovir treatment for congenital cytomegalovirus infection

Takashi Imamura(Fukushima Medical University), Mitsuaki Hosoya, Kazufumi Ikuta(National Institutes of Health), Hiroshi Ogawa(Kumamoto University), Nobuo Momoi(Fukushima Medical University), Naoki Inoue(Mukogawa Women's University), Kimisato Asano(Fukushima Medical University), Tatsuo Suzutani(Fukushima Medical University), Mika Nomoto(Fukushima Medical University), Takamichi Matsui(Fukushima Medical University)
Pediatrics International
April 1, 2011
10.1111/j.1442-200x.2010.03217.x
Cited by 11

Related Papers

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Human Herpesvirus 6B Genome Sequence: Coding Content and Comparison with Human Herpesvirus 6A
|Journal of Virology|1999|342
ICTV Virus Taxonomy Profile: Herpesviridae 2021
|Journal of General Virology|2021|255
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
|Clinical Cancer Research|2015|180
Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis
|Nature Medicine|1999|176